BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy Now?

Is BCRX a good stock to buy? We came across a bullish thesis on BioCryst Pharmaceuticals, Inc. on TradersPro’s Substack. In ...

How an RNA-binding protein detects and responds to non-optimal codon usage in human cells

Human genes are written in long strings of three-letter units composed of four different nucleotides. These units—or codons—specify one of many amino acids, the building blocks of proteins. Multiple ...
PharmiWeb

PlasmidFactory’s Minicircle DNA: Raising the Bar in Gene and Cell Therapy

Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...
JD Supra

Meanwhile, Back at the PTAB with CRISPR – Update

Neither the Parties nor the Patent Trial and Appeal Board (PTAB) have been resting in addressing the decision by the Federal Circuit that vacated ...
New Scientist

Probiotic cream that ramps up heat production could prevent frostbite

Genetically engineering bacteria that live on our skin could prevent frostbite and hypothermia in extreme environments ...
Gut

Molecular and cellular consequences of tumour-autonomous IL-6 signalling in intrahepatic cholangiocarcinoma

Background High serum levels of interleukin 6 (IL-6) predict poor prognosis in intrahepatic cholangiocarcinoma (iCCA), a malignancy that often develops in a chronically inflamed milieu . Here, tumour ...

Ubigene Highlights Gene Knockout Cell Line Capabilities to Help Accelerate Research Efficiency

EZ-editor™ platform, large-scale cell resources, and standardised workflows support faster and more reliable knockout ...
sharewise

CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to Know

CRISPR Therapeutics AG (CRSP) closed at $47.69 in the latest trading session, marking a -4.79% move from the prior day. The ...